Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Candida - skin - Management
Basis for recommendation

  • CKS found no guidelines on when to refer people with candida infection of the skin. Therefore the recommendations have been based on the following rationale:
    • If management in primary care with a topical imidazole followed by oral fluconazole has not been successful, CKS advises referral to a dermatologist to ensure that the diagnosis is correct and for consideration of further treatment which is more appropriate to a secondary care setting.
    • People with widespread infection or recurrent episodes may have underlying predisposing factors (e.g. immunocompromise) which require investigation, and may need further treatment only available in secondary care.

© NHS Institute for Innovation and Improvement